神經血栓除去裝置市場規模、佔有率和成長分析：按器械類型、手術、年齡層、治療類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球神經血栓除去裝置市值為 8.244 億美元，預計到 2025 年將成長至 8.8046 億美元，到 2033 年將成長至 14.9032 億美元，在預測期（2026-2033 年）內複合年成長率為 6.8%。

全球血栓除去裝置市場主要受人口老化和缺血性中風發病率上升的驅動，導致機械取栓術日益成為標準治療方法。該市場涵蓋了可程式設計血栓摘取支架和抽吸導管等創新解決方案，旨在有效清除腦血栓並恢復血流，這對於降低致殘率和醫療成本至關重要。臨床證據的進步和治療時間的延長正在推動市場成長，擴大了適用患者群體，並促進了投資。隨著越來越多的卒中中心建立介入神經放射學室並加強多學科培訓，對各種器材的需求也不斷成長。這促進了區域間合作，改善了患者預後，並使製造商能夠擴大營運規模、降低成本並進入新市場。

全球神經血栓除去裝置市場的成長要素

高品質影像系統的進步顯著提升了臨床醫生識別血管閉塞部位和即時有效部署神經血栓除去裝置的能力，從而改善了手術效果。影像品質的提升降低了手術的不確定性，增強了醫院對神經血栓切除技術的信心。此外，影像技術的進步也為創新裝置和技術的研發以及醫護人員進行神經血栓切除術的專業培訓鋪平了道路。這些因素不僅提升了醫院提供的此類服務的整體吸引力，也促進了全球神經血栓除去裝置市場的廣泛接受和成長。

全球神經血栓除去裝置市場的限制因素

神經血栓切除術的複雜性，以及介入神經放射學所需的專業技能，對市場擴張構成了重大挑戰。這種複雜性限制了能夠提供此類服務的醫療機構數量。此外，漫長的學習曲線、對協調完善的中風系統以及訓練有素的人員的需求，迫使醫院投入大量資源和精力來開發適合此類手術的方案。而且，缺乏專業知識和系統性的培訓計畫會導致推廣應用延遲和轉診模式混亂，最終導致許多地區儘管存在臨床需求，卻無法滿足這些設備的需求。

神經血栓除去裝置的全球市場趨勢

全球血栓除去裝置市場正經歷著一個顯著的成長趨勢，這主要得益於人工智慧技術在影像和手術規劃中的應用。這項技術進步實現了個人化器械選擇，並為臨床醫生提供即時指導，從而能夠根據每位患者的解剖結構和血栓特徵制定個體化的神經血栓切除方案。基於演算法的導航和工作流程調整增強了臨床決策能力，同時最大限度地減少了手術操作的差異性，使經驗不足的醫生也能從中受益。這些創新促進了器材製造商和醫療系統之間更緊密的合作，不斷改進工具設計和培訓流程。因此，這種持續改進的循環提高了產品採用率，並提升了不同醫院環境下的患者照護水準。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球神經血栓除去裝置市場規模：依器械類型分類

• 血栓摘取支架
• 吸力/吸力裝置
• 血栓除去裝置
• 球囊引導管
• 支撐導管和微導管

全球神經血栓除去裝置市場規模：依方法分類

• 抽吸血栓切除手術
• 機械血栓切除術
• 聯合方法

全球神經血栓除去裝置市場規模：依年齡層別分類

• 成人
• 老年人

全球神經血栓除去裝置市場規模：依手術類型分類

• 微創手術
• 使用導管的神經血管手術

全球神經血栓除去裝置市場規模：按應用領域分類

• 急性缺血性腦中風
• 出血性中風
• 神經血管閉塞

全球神經血栓除去裝置市場規模：依最終用戶分類

• 醫院
• 門診手術中心（ASC）
• 神經科專科診所
• 其他

全球神經血栓除去裝置市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Stryker Corporation
• Penumbra, Inc.
• Johnson & Johnson
• Terumo Corporation
• MicroPort Scientific Corporation
• Integer Holdings Corporation
• Merit Medical Systems, Inc.
• Rapid Medical
• Acandis GmbH
• Asahi Intecc Co., Ltd.
• Phenox GmbH
• Balt Group
• Cerus Endovascular
• Perflow Medical Ltd.
• Abbott Laboratories
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Cook Medical
• Kaneka Corporation

結論與建議

Global Neurothrombectomy Devices Market size was valued at USD 824.4 Million in 2024 and is poised to grow from USD 880.46 Million in 2025 to USD 1490.32 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global market for neurothrombectomy devices is significantly influenced by an aging population and the increasing prevalence of ischemic strokes, which leads to a focus on mechanical clot retrieval as the standard treatment. This market includes innovative solutions such as programmable stent retrievers and aspiration catheters designed to effectively eliminate cerebral thrombi and restore blood flow, crucial for reducing disability and healthcare costs. Advances in clinical evidence and an expansion of treatment timeframes are propelling market growth, widening patient eligibility and encouraging investment. As more stroke centers establish neurointerventional suites and enhance multidisciplinary training, the demand for diverse device options rises, fostering regional collaboration, improving patient outcomes, and allowing manufacturers to scale operations, lower costs, and penetrate new markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurothrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurothrombectomy Devices Market Segments Analysis

Global neurothrombectomy devices market is segmented by device type, technique, age group, procedure type, application, end user and region. Based on device type, the market is segmented into Stent Retrievers, Aspiration / Suction Devices, Clot Retrieval Devices, Balloon Guide Catheters and Support Catheters & Microcatheters. Based on technique, the market is segmented into Aspiration Thrombectomy, Mechanical Thrombectomy and Combined Technique. Based on age group, the market is segmented into Adult and Geriatric. Based on procedure type, the market is segmented into Minimally Invasive Procedures and Catheter-Based Neurovascular Procedures. Based on application, the market is segmented into Acute Ischemic Stroke, Hemorrhagic Stroke and Neurovascular Occlusions. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Neurology Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neurothrombectomy Devices Market

The advancement of high-quality imaging systems has significantly enhanced clinicians' ability to identify blockages and effectively deploy neurothrombectomy devices in real-time, leading to improved procedural outcomes. This elevated imaging quality has mitigated uncertainties associated with procedures, fostering greater confidence among hospitals in utilizing neurothrombectomy techniques. Additionally, enhanced imaging has paved the way for developing innovative devices and procedures, along with specialized training for medical professionals in delivering neurothrombectomy services. This amalgamation of factors has not only improved the overall appeal of these services offered by hospitals but has also contributed to the widespread acceptance and growth of the global neurothrombectomy devices market.

Restraints in the Global Neurothrombectomy Devices Market

The intricate nature of neurothrombectomy procedures, combined with the specialized skills required of neurointerventionalists, poses significant challenges for market expansion. This complexity limits the number of healthcare centers capable of providing such services. Moreover, the lengthy learning curve and the necessity for well-coordinated stroke systems and trained personnel compel hospitals to invest substantial resources and commitment to develop appropriate programs for these procedures. In addition, the absence of specialized expertise and structured training programs can lead to slow adoption rates and disrupted referral patterns, ultimately resulting in unmet demand for these devices in numerous regions, despite their clinical necessity.

Market Trends of the Global Neurothrombectomy Devices Market

The Global Neurothrombectomy Devices market is witnessing a significant trend driven by the integration of AI technologies into imaging and procedural planning. This advancement enables personalized device selection and provides real-time guidance to clinicians, allowing for tailored neurothrombectomy approaches based on individual patient anatomy and clot characteristics. Algorithm-based navigation and workflow orchestration enhance clinical decision-making while minimizing procedural variability, benefiting even less experienced operators. Such innovations foster closer collaborations between device manufacturers and healthcare systems, refining tool designs and training pathways. Consequently, this continuous cycle of iterative improvements enhances product adoption rates and elevates patient care standards across diverse hospital settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Neurothrombectomy Devices Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Stent Retrievers
• Aspiration / Suction Devices
• Clot Retrieval Devices
• Balloon Guide Catheters
• Support Catheters & Microcatheters

Global Neurothrombectomy Devices Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Aspiration Thrombectomy
• Mechanical Thrombectomy
• Combined Technique

Global Neurothrombectomy Devices Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adult
• Geriatric

Global Neurothrombectomy Devices Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Minimally Invasive Procedures
• Catheter-Based Neurovascular Procedures

Global Neurothrombectomy Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Acute Ischemic Stroke
• Hemorrhagic Stroke
• Neurovascular Occlusions

Global Neurothrombectomy Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Neurology Clinics
• Others

Global Neurothrombectomy Devices Market Size & CAGR (2026-2033)

• North America (Device Type, Technique, Age Group, Procedure Type, Application, End User)
  • US
  • Canada
• Europe (Device Type, Technique, Age Group, Procedure Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Technique, Age Group, Procedure Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Technique, Age Group, Procedure Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Technique, Age Group, Procedure Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phenox GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Endovascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perflow Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations